<p>(a) Infectivity of AsPC-1 peritoneal tumors with AdΔCAR-LucEGFP-PFW. The various amounts (1, 3, 10×10<sup>7</sup> PFU) of adenovirus vectors (AdΔCAR-LucEGFP-PFW or AdΔCAR-LucEGFP) were intraperitoneally injected once into the mice with peritoneal dissemination of AsPC-1 cells (n = 3∼4). Two days after the injection, peritoneal tumors were harvested and the luciferase activity was measured. The graph presents the luciferase activity per mg of tumor tissue. AdΔCAR-LucEGFP is a replication-incompetent adenovirus vector ablated for CAR binding and expresses a fusion gene of luciferase and EGFP. In AdΔCAR-LucEGFP-PFW, a PFWSGAV peptide is inserted in HI-loop of fiber knob in AdΔCAR-LucEGFP. i.p.; intraperitoneal injection. (b) Infectivity of ...
Objective: To develop an adenovirus system to deliver biologically active peptides or proteins such ...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
Adenovirus serotype 5 (Ad5) is widely used as an oncolytic agent for cancer therapy. However, its in...
<p>(a) Infectivity of organs with adenovirus vectors. The mice were injected intraperitoneally with ...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
<p>(a) Luciferase activities following infection of adenovirus vectors <i>in vitro</i>. The AsPC-1, ...
Application of human adenovirus type 5 (Ad5) derived vectors for cancer gene therapy has been limite...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
The aim of this study was to change adenovirus tropism by chemical modification of the fiber knobs w...
Purpose: In vivo imaging of the spread of oncolytic viruses using the Na/I symporter (NIS) has been ...
Application of human adenovirus type 5 (Ad5) derived vectors for cancer gene therapy has been limite...
Copyright © 2003 Elsevier Science (USA). All rights reserved.The efficiency of cancer gene therapy w...
Copyright © 2003 Elsevier Science (USA). All rights reserved.The efficiency of cancer gene therapy w...
<p><b>A</b>. Schematic representation of adenoviral shuttle vector that overexpresses LPAATβ driven ...
Objective: To develop an adenovirus system to deliver biologically active peptides or proteins such ...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
Adenovirus serotype 5 (Ad5) is widely used as an oncolytic agent for cancer therapy. However, its in...
<p>(a) Infectivity of organs with adenovirus vectors. The mice were injected intraperitoneally with ...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
The targeting of gene transfer at the cell-entry level is one of the most attractive challenges in v...
<p>(a) Luciferase activities following infection of adenovirus vectors <i>in vitro</i>. The AsPC-1, ...
Application of human adenovirus type 5 (Ad5) derived vectors for cancer gene therapy has been limite...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
The aim of this study was to change adenovirus tropism by chemical modification of the fiber knobs w...
Purpose: In vivo imaging of the spread of oncolytic viruses using the Na/I symporter (NIS) has been ...
Application of human adenovirus type 5 (Ad5) derived vectors for cancer gene therapy has been limite...
Copyright © 2003 Elsevier Science (USA). All rights reserved.The efficiency of cancer gene therapy w...
Copyright © 2003 Elsevier Science (USA). All rights reserved.The efficiency of cancer gene therapy w...
<p><b>A</b>. Schematic representation of adenoviral shuttle vector that overexpresses LPAATβ driven ...
Objective: To develop an adenovirus system to deliver biologically active peptides or proteins such ...
Targeting viral vectors to certain tissues in vivo has been a major challenge in gene therapy. Cell ...
Adenovirus serotype 5 (Ad5) is widely used as an oncolytic agent for cancer therapy. However, its in...